Valproate prescriptions for nonepilepsy disorders in reproductive-age women

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 97, Issue 6, 2013, Pages 403-408

  Adedinsewo, Demilade A ^a,b   Thurman, David J ^b   Luo, Yao Hua ^b   Williamson, Rebecca S ^a   Odewole, Oluwaseun A ^c   Oakley, Godfrey P ^a  

^a EMORY UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Anticonvulsants; Congenital abnormalities; Psychiatry; Valproic acid; Women's health

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; CLORAZEPATE; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; FOSPHENYTOIN SODIUM; GABAPENTIN; LAMOTRIGINE; METHYLPHENOBARBITAL; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALCOHOLISM; ARTICLE; BRAIN DISEASE; CEREBRAL PALSY; DRUG DEPENDENCE; DRUG INDICATION; DRUG USE; FEMALE; GENITAL BLEEDING; HEAD AND NECK DISEASE; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MENSTRUATION DISORDER; MENTAL DISEASE; MIGRAINE; MOOD DISORDER; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; OVARY CANCER; PAIN; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SCHIZOPHRENIA; UTERUS CANCER; WOMEN'S HEALTH;

ADOLESCENT; ADULT; ANTICONVULSANTS; BIPOLAR DISORDER; CONGENITAL ABNORMALITIES; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; HUMANS; NERVOUS SYSTEM DISEASES; PREVALENCE; UNITED STATES; VALPROIC ACID;

EID: 84879780549     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.23147     Document Type: Article

References (41)

1. Ackers R, Besag FM, Wade A, et al. 2009. Changing trends in antiepileptic drug prescribing in girls of child-bearing potential. Arch Dis Child 94:443-447.
2. Adab N, Kini U, Vinten J, et al. 2004. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 75:1575-1583.
3. American Psychiatric Association. 2002. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 159(Suppl):1-50.
4. Bjerkedal T, Czeizel A, Goujard J, et al. 1982. Valproic acid and spina bifida. Lancet 2:1096.
5. CDC. 1982. Valproic acid and spina bifida: a preliminary report-France. MMWR Morb Mortal Wkly Rep 31:565-566.
6. Eurap Study Group. 2009. Utilization of antiepileptic drugs during pregnancy: comparative patterns in 38 countries based on data from the EURAP registry. Epilepsia 50:2305-2309.
7. FDA Pregnancy Category Definitions (summarized from 21 CFR 201.57). 03/07/2011 ed. Drug safety and availability: risk of oral clefts (cleft lip and/or palate) in infants born to mothers taking Topamax (Topiramate).
8. FDA US. 2009. Stavzor (valproic acid) prescribing information. Silver Spring, MD: FDA.
9. Finer LB, Henshaw SK. 2006. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspectives on sexual and reproductive health 38:90-96.
10. Friedman BW, Grosberg BM. 2009. Diagnosis and management of the primary headache disorders in the emergency department setting. Emerg Med Clin North Am 27:71-87, viii.
11. Gilboa SM, Broussard CS, Devine OJ, et al. 2011. Influencing clinical practice regarding the use of antiepileptic medications during pregnancy: modeling the potential impact on the prevalences of spina bifida and cleft palate in the United States. Am J Med Genet C Semin Med Genet 157:234-246.
12. Goodwin GM, Consensus Group of the British Association for Psychopharmacology. 2009. Evidence-based guidelines for treating bipolar disorder: revised second edition-recommendations from the British Association for Psychopharmacology. J Psychopharmacol (Oxford, England) 23:346-388.
13. Harden CL, Meador KJ, Pennell PB, et al. 2009a. Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 50:1237-1246.
14. Harden CL, Meador KJ, Pennell PB, et al. 2009b. Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 73:133-141.
15. Hixson JD. 2010. Stopping antiepileptic drugs: when and why? Curr Treat Options Neurol 12:434-442.
16. Jentink J, Loane MA, Dolk H, et al. 2010. Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med 362:2185-2193.
17. Johannessen Landmark C, Larsson PG, Rytter E, Johannessen SI. 2009. Antiepileptic drugs in epilepsy and other disorders-a population-based study of prescriptions. Epilepsy Res 87:31-39.
18. Johannessen Landmark C. 2008. Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy. CNS Drugs 22:27-47.
19. Kaufman KR. 2011. Antiepileptic drugs in the treatment of psychiatric disorders. Epilepsy Behav 21:1-11.
20. Meador KJ, Baker GA, Browning N, et al. 2009a. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 360:1597-1605.
21. Meador KJ, Baker GA, Browning N, et al. 2013. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol 12:244-252.
22. Meador KJ, Penovich P, Baker GA, et al. 2009b. Antiepileptic drug use in women of childbearing age. Epilepsy Behav 15:339-343.
23. Morrow J, Russell A, Guthrie E, et al. 2006. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 77:193-198.
24. National Center for Health Statistics. 2007a. National Ambulatory Medical Care Survey (NAMCS) public use micro-data file documentation.
25. National Center for Health Statistics. 2007b. National Hospital Ambulatory Medical Care Survey (NHAMCS) public use micro-data file documentation.
26. National Center for Health Statistics. 2010. Ambulatory health care data. NCHS, Centers for Disease Control and Prevention.
27. National Institutes of Health. 2007. Spina bifida fact sheet. National Institute of Neurological Disorders and Stroke.
28. Nicolson A, Appleton RE, Chadwick DW, Smith DF. 2004. The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies. J Neurol Neurosurg Psychiatry 75:75-79.
29. Ornoy A. 2009. Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Reprod Toxicol 28:1-10.
30. Peckman H. 2010. The U.S. Food and Drug Adminstration (FDA) has assigned pregnancy category D to valproate. N C Med J 71:396-398.
31. Pennell PB. 2003. Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology 61(Suppl 2):S35-S42.
32. Rapcencu AE, Lindhout D, Bulk S. 2012. Frequently asked questions on epilepsy, pregnancy and lactation: a EURAP-NL report. Seizure 21:606-609.
33. Schmidt D. 2011. AED discontinuation may be dangerous for seizure-free patients. J Neural Transm 118:183-186.
34. Schwarz EB, Maselli J, Norton M, Gonzales R. 2005. Prescription of teratogenic medications in United States ambulatory practices. Am J Med 118:1240-1249.
35. Shallcross R, Bromley RL, Irwin B, et al. 2011. Child development following in utero exposure: levetiracetam vs sodium valproate. Neurology 76:383-389.
36. Shih JJ, Ochoa JG. 2009. A systematic review of antiepileptic drug initiation and withdrawal. Neurologist 15:122-131.
37. Teratology Society Public Affairs Committee. 1994. FDA classification of drugs for teratogenic risk. Teratology 49:446-447.
38. Tomson T, Battino D, Bonizzoni E, et al. 2011. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 10:609-617.
39. Werler MM, Ahrens KA, Bosco JL, et al. 2011. Use of Antiepileptic Medications in Pregnancy in Relation to Risks of Birth Defects. Ann Epidemiol 21:842-850.
40. Wyszynski DF, Nambisan M, Surve T, et al. 2005. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 64:961-965.
41. Yonkers KA, Wisner KL, Stewart DE, et al. 2009. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry 31:403-413.